PillTrek is a mini capsule that senses gut biomarkers in real time. It enables advanced GI diagnostics without invasive ...

PillTrek is a revolutionary smart capsule that performs in vivo electrochemical measurements, paving the way for improved gut ...

A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

If pre-cancerous cells are found, treatment can be offered to remove the cells through endoscopy or a procedure known as ...

CapsoVision, Inc CV IPO will take place July, 02 on the NASDAQ exchange under the ticker CV. The company is offering shares at an expected price between $5.00 and $5.50 per share with an insider ...

A new "pill-on-a-string" capsule sponge test offers a faster, less invasive, and more accessible method for early throat ...

In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in ...

“Our findings suggest that the capsule sponge could help stratify patients with Barrett’s esophagus by risk and that half of ...

Caltech's PillTrek smart capsule measures just 7 millimeters in diameter and 25 millimeters in length, making it smaller than ...

Learn about the "pill-on-a-thread" that could replace endoscopies for half of all patients at risk of developing esophageal cancer.

CapsoVision has filed to go public, with plans to raise up to $30 million to support the development of its swallowable capsule camera and screening programs for gastrointestinal diseases ...

The global capsule endoscopy market is projected to grow at a compound annual growth rate (CAGR) of 9.61% from 2024 to 2030. The increasing prevalence of gastrointestinal disorders, such as Crohn ...